SUNPHARMA.NS Sun Pharmaceutical Industries Ltd.
Price history
Price is the daily close from stored Kite history. The other metrics pair that daily price with the company's periodic filings — each fundamental (revenue, EPS, equity…) is held flat at its latest filed value between annual filings, so a ratio steps at each filing and moves daily only through its price term. A metric with no input on file for this company (e.g. EV/EBITDA for a bank, which has no EBIT) is shown as unavailable, never guessed. Share-count-based metrics use the latest diluted share count against split/bonus-adjusted prices.
Technical indicators
ℹ These reflect only the stock's recent price and volume behavior — not the company's fundamentals — and are not a recommendation to buy or sell. Standard published parameters are used throughout (see each chart's own label); a company with too little stored price history for a given indicator's lookback window shows that plainly below rather than a garbage or misleading value.
MACD (12,26,9), Stochastic Oscillator (14,3) and Money Flow Index (14-day) each carry their own published reference lines/bands (20/80 for the oscillator readings) where one is standard. ADX includes +DI/-DI for direction alongside trend strength; a dashed line marks the commonly published 25 "trending market" reading. ATR is shown in raw rupees here; the price/volume preset screen (below, and on the Screener page) reports it as a % of price so it's comparable across stocks at different price levels. Computed from the same stored daily OHLCV history as the price chart above — no new data source.
Delivery volume
| Date | Traded Qty | Delivery Qty | Delivery % |
|---|---|---|---|
| 2026-08-28 | 1140742 | 688877 | 60.39% |
| 2026-08-27 | 1107552 | 718706 | 64.89% |
| 2026-08-26 | 648845 | 440446 | 67.88% |
| 2026-08-25 | 1221044 | 708036 | 57.99% |
| 2026-08-24 | 2317987 | 1713184 | 73.91% |
| 2026-08-21 | 1491953 | 1044785 | 70.03% |
| 2026-08-20 | 893691 | 517472 | 57.90% |
| 2026-08-19 | 1566692 | 1034191 | 66.01% |
| 2026-08-18 | 1819169 | 1051823 | 57.82% |
| 2026-08-17 | 1893086 | 1250365 | 66.05% |
| 2026-08-14 | 881282 | 609862 | 69.20% |
| 2026-08-13 | 1216049 | 758400 | 62.37% |
| 2026-08-12 | 1536383 | 1073859 | 69.90% |
| 2026-08-11 | 2125972 | 1446998 | 68.06% |
| 2026-08-10 | 1726946 | 1171116 | 67.81% |
| 2026-08-07 | 2425268 | 1526284 | 62.93% |
| 2026-08-06 | 1864891 | 1175733 | 63.05% |
| 2026-08-05 | 2152829 | 1452281 | 67.46% |
| 2026-08-04 | 1452888 | 977243 | 67.26% |
| 2026-08-03 | 3972351 | 2629889 | 66.20% |
Delivery quantity/percentage from the NSE bhavcopy (DELIV_QTY/DELIV_PER) — the share of that day's traded volume that actually settled into a demat account, rather than being squared off intraday. A higher delivery percentage is commonly read as genuine accumulation/distribution rather than speculative same-day trading; this describes recent trading PATTERN, not the company itself, and is not a recommendation to buy or sell. A blank cell is a day NSE itself published no figure for, never a zero. Run python manage.py refresh_delivery_volumes --tickers SUNPHARMA.NS to fetch more history.
Insider trading activity
| Disclosed | Person | Category | Type | Mode | Quantity | Value (₹) | Resulting stake | |
|---|---|---|---|---|---|---|---|---|
| 30 Aug 2023 | RAKSHA VALIA-Person Acting in Concert and immediate relative of Non Executive Non Independent Director (Member of Promoter Group) | Promoter Group | Pledge | Off Market | 2020000 | 2256340000 | 1.20% | XBRL |
| 23 May 2023 | RAKSHA VALIA-Person Acting in Concert and immediate relative of Non Executive Non Independent Director (Member of Promoter Group) | Promoter Group | Pledge | Off Market | 1000000 | 937450000 | 1.20% | XBRL |
| 29 Mar 2023 | ADITYA MEDISALES LIMITED | Promoter Group | Pledge Revoke | Off Market | 5990000 | 5893860500 | 1.67% | XBRL |
| 22 Mar 2023 | RAKSHA VALIA-Person Acting in Concert and immediate relative of Non Executive Non Independent Director (Member of Promoter Group) | Immediate relative | Pledge | Off Market | 1650000 | 1585980000 | 1.20% | XBRL |
| 20 Mar 2023 | Sailesh T. Desai | Director | Sell | Market Sale | 4000 | 3862970 | 0.10% | XBRL |
| 09 Mar 2023 | Shanghvi Finance Private Limied | Promoter Group | Pledge Revoke | Off Market | 119837 | 115672664 | 40.30% | XBRL |
| 06 Mar 2023 | RAKSHA VALIA-Person Acting in Concert and immediate relative of Non Executive Non Independent Director (Member of Promoter Group) | Immediate relative | Pledge | Off Market | 1160000 | 1121604000 | 1.20% | XBRL |
| 06 Mar 2023 | RAKSHA VALIA-Person Acting in Concert and immediate relative of Non Executive Non Independent Director (Member of Promoter Group) | Immediate relative | Pledge Revoke | Off Market | 8101000 | 7771289300 | 1.20% | XBRL |
| 23 Feb 2023 | RAKSHA VALIA-Person Acting in Concert and immediate relative of Non Executive Non Independent Director (Member of Promoter Group) | Immediate relative | Pledge | Off Market | 2420000 | 2343891000 | 1.20% | XBRL |
| 23 Feb 2023 | RAKSHA VALIA-Person Acting in Concert and immediate relative of Non Executive Non Independent Director (Member of Promoter Group) | Immediate relative | Pledge | Off Market | 1190000 | 1152574500 | 1.20% | XBRL |
| 20 Feb 2023 | Sailesh T. Desai | Key Managerial Personnel | Pledge Revoke | Off Market | 15000 | 14947500 | 0.10% | XBRL |
| 07 Feb 2023 | ADITYA MEDISALES LIMITED | Promoter Group | Pledge | Off Market | 6000000 | 6141000000 | 1.67% | XBRL |
| 27 Dec 2022 | RAKSHA VALIA-Person Acting in Concert and immediate relative of Non Executive Non Independent Director (Member of Promoter Group) | Immediate relative | Pledge | Off Market | 3000000 | 3000150000 | 1.20% | XBRL |
| 23 Dec 2022 | Sailesh T. Desai | Director | Sell | Market Sale | 5000 | 5140678 | 0.10% | XBRL |
| 23 Dec 2022 | Sailesh T. Desai | Director | Sell | Market Sale | 2000 | 2050000 | 0.10% | XBRL |
| 23 Dec 2022 | Sailesh T. Desai | Director | Sell | Market Sale | 2000 | 2043186 | 0.10% | XBRL |
| 22 Dec 2022 | RAKSHA VALIA-Person Acting in Concert and immediate relative of Non Executive Non Independent Director (Member of Promoter Group) | Promoter Group | Pledge | Off Market | 450000 | 452520000 | 1.20% | XBRL |
| 08 Dec 2022 | PRITI GANDHI | Immediate relative | Sell | Market Sale | 3000 | 3090000 | 0.00% | XBRL |
| 08 Dec 2022 | Nilesh Gandhi | Employees/Designated Employees | Sell | Market Sale | 2000 | 2057080 | 0.00% | XBRL |
| 05 Dec 2022 | RAKSHA VALIA-Person Acting in Concert and immediate relative of Non Executive Non Independent Director (Member of Promoter Group) | Immediate relative | Pledge Revoke | Off Market | 60000 | 62400000 | 1.20% | XBRL |
SEBI PIT (Prohibition of Insider Trading) Regulation 7 disclosures — designated persons (promoters, directors, KMPs, and their immediate relatives) reporting their own dealing in the company's securities, as NSE publishes them. Distinct from the SAST (Regulation 29 substantial-acquisition) filings on the market-wide SAST activity page. Public record only — this is descriptive disclosure data, not a signal, and is not a recommendation to buy or sell. Run python manage.py refresh_insider_trades --tickers SUNPHARMA.NS to fetch more.
Extract this company (financials + ratios + citations): CSV · XLSX
Full statements: Profit & Loss · Balance Sheet · Cash Flow · Compare with 46 peers in Healthcare · Trace Score
Ratios
This is cash paid during the fiscal year, not a per-share rate declared for it (no such element exists in the filing data) — timing can straddle interim/final dividends across years, and pre-FY2020-21 figures may include the since-abolished Dividend Distribution Tax, reading higher than later years for that reason alone.
Growth & earnings trend
Revenue & Profit CAGR
Operating Margin Trend
ROCE Trajectory
Earnings Quality
No persistent gap detected
Net Profit CAGR 10.65% vs CFO CAGR 35.79% over 3.0y (2023-03-31 → 2026-03-31); most recent year: Net Profit +5.04% vs CFO -11.75%
Sector-Relative Percentile (Healthcare)
Quarterly trend
| Metric (to shareholders basis) | Q4 FY2023-24 | Q1 FY2024-25 | Q2 FY2024-25 | Q3 FY2024-25 | Q4 FY2024-25 | Q1 FY2025-26 | Q2 FY2025-26 | Q3 FY2025-26 | Q4 FY2025-26 | Q1 FY2026-27 | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹11,982.90 Cr. | ₹12,652.75 Cr. | ₹13,291.39 Cr. | ₹13,675.46 Cr. | ₹12,958.84 Cr. | ₹13,851.40 Cr. | ₹14,478.31 Cr. | ₹15,520.54 Cr. | ₹14,611.79 Cr. | ₹15,299.88 Cr. | RevenueFromOperations |
| Net Profit | ₹2,654.58 Cr. incl. minority ₹2,658.74 Cr. | ₹2,835.62 Cr. incl. minority ₹2,860.51 Cr. | ₹3,040.16 Cr. incl. minority ₹3,037.33 Cr. | ₹2,903.38 Cr. incl. minority ₹2,912.98 Cr. | ₹2,149.88 Cr. incl. minority ₹2,153.93 Cr. | ₹2,278.63 Cr. incl. minority ₹2,292.87 Cr. | ₹3,117.95 Cr. incl. minority ₹3,124.95 Cr. | ₹3,368.81 Cr. incl. minority ₹3,381.17 Cr. | ₹2,714.03 Cr. incl. minority ₹2,709.66 Cr. | ₹2,894.79 Cr. incl. minority ₹2,901.23 Cr. | ProfitOrLossAttributableToOwnersOfParent |
Primary figures are Revenue from Operations and Net Profit attributable to shareholders — the basis the ratios use. Where they differ, the companion Gross revenue (incl. inter-segment) and incl. minority net profit (the totals a news headline usually quotes) are shown beneath, each traceable to its own XBRL element. Quarters shown are however many are actually stored (up to 10) — run python manage.py refresh_quarterly_trend --tickers SUNPHARMA.NS to fetch more.
Source document — income statement (FY2025-26, raw filing line items)
View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.
| ProfitOrLossAttributableToOwnersOfParent | 114794200000.0 |
| PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital | 2399300000.0 |
Source document — balance sheet (FY2025-26, raw filing line items)
View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.
| CurrentAssets | 638602900000.0 |
| CurrentLiabilities | 226220400000.0 |
| EquityAttributableToOwnersOfParent | 835700900000.0 |
| BorrowingsCurrent + BorrowingsNoncurrent | 40816100000.0 |